로딩 중…
지수 로딩 중…
HYUNDAI PHARMACEUTICAL CO., LTD
004310· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩8,150-4.12%
2026-06-19
Price Chart
HYUNDAI PHARMACEUTICAL CO., LTD+134.20%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 260.80B KRW |
| Revenue | 195.16B KRW |
| Net Income | 811,296 KRW |
| Total Assets | 224.31B KRW |
| Net Assets | 134.81B KRW |
| Employees | 401 |
| Value | |
| P/B | 1.93x |
| P/S | 1.34x |
| EV/EBITDA | 98.01x |
| FCF Yield | -1.81% |
| Profitability | |
| ROE | 0.00% |
| ROA | 0.00% |
| Op. Margin | 1.53% |
| Revenue Growth | 7.82% |
| Financial Health | |
| Debt Ratio | 166.38% |
| Total Debt | 49.80B KRW |
| FCF | -4.73B KRW |
| Cash | 18.67B KRW |
| Current Ratio | 1.28x |
| Net Debt/EBITDA | 10.45x |
| Dividend | |
| Div. Yield | 0.35% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | 134.20% |
| 1M Return | 12.41% |
| From 52W High | -48.93% |
| 1Y MDD | -61.58% |
| Trading | |
| Volume | 14,841,315 shares |
| Foreign Own. | 6.80% |
| Per Share | |
| EPS | 123 KRW |
| BPS | 4,878 KRW |
Company Info
Hyundai Pharmaceutical, established in 1965 and listed on the stock market in 1978, is a pharmaceutical and beverage manufacturing and sales company. It produces and supplies both specialized prescription drugs (such as hypertension treatment Tenormin) and over-the-counter drugs (like alopecia treatment Minoxidil Solution and mosquito bite relief Burmuli) to hospitals, clinics, and pharmacies nationwide. The company is currently conducting Phase 2b clinical trials for HDNO-1605, an innovative new drug for diabetes, and actively seeking improved new drugs to enhance medication adherence in the cardiovascular sector. Hyundai Pharmaceutical is headquartered in Cheonan-si, Chungcheongnam-do.